You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol

Citation Tools

Article menu

Download PDFPDF

XML
Mental health
Protocol
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ishøy PL, Knop FK, Broberg BV, et al
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
BMJ Open 2014;4:e004158. doi: 10.1136/bmjopen-2013-004158